CIA
ASTH icon

Caerus Investment Advisors’s Astrana Health ASTH Stock Holding History

Caerus Investment Advisors’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-8,000
Closed -$247K – 42
2023
Q3 		$247K Buy
+8,000
New +$276K 0.25% 29

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Caerus Investment Advisors's ASTH Position: Q4 2023 in Review

Caerus Investment Advisors sold out of Astrana Health (ASTH) in Q4 2023, closing a stake of 8,000 shares — an estimated $247K sold.

Caerus Investment Advisors first reported a position in ASTH in Q3 2023 and held it in 1 quarter. The position peaked at $247K in Q3 2023. 143 funds tracked by Wall St. Rank hold ASTH as of Q4 2023.

  • Caerus Investment Advisors reported no remaining Astrana Health position as of Q4 2023 after selling out during the quarter.
  • Caerus Investment Advisors sold 8,000 Astrana Health shares in Q4 2023, an estimated $247K.
  • Caerus Investment Advisors first reported a position in Astrana Health in Q3 2023 and held it in 1 quarter.
  • Caerus Investment Advisors's Astrana Health position peaked at $247K in Q3 2023.
  • 143 funds tracked by Wall St. Rank held Astrana Health as of Q4 2023.

Based on Caerus Investment Advisors's 13F filing for Q4 2023, filed 19 Jan 2024.